Read about challenges faced and overcome by our scientists. See how other companies put CoreRx™ teams to work for them. In one case, our client had already progressed to clinical trials; however, they discovered a problem with the stability of their product. In another case, we reformulated a drug made from two Class II controlled substances within the client's timeline and without infringing on intellectual property.

